Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

An Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) Vaccine

This study has been completed.
Information provided by (Responsible Party):
Sinovac Biotech Co., Ltd Identifier:
First received: January 2, 2012
Last updated: November 27, 2013
Last verified: March 2013